Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Michel

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Heart Failure|April 29, 2020
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity: all you need is a meta-analysis? ReplyLars Michel, Tienush Rassaf, Matthias Totzeck
Herz|June 10, 2020
Oncocardiology: new challenges, new opportunitiesLars Michel, Dirk Schadendorf, Tienush Rassaf
Herz|June 14, 2020
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular systemLars Michel, Matthias Totzeck, Lorenz Lehmann, et al.
Current Heart Failure Reports|April 18, 2024
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac AmyloidosisSimon Wernhart, Lars Michel, Alexander Carpinteiro, et al.
International Journal of Cardiology. Heart & Vasculature|January 30, 2025
The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?Tobias Lerchner, Anke Fender, Dobromir Dobrev, et al.
European Heart Journal|March 8, 2022
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesMatthias Totzeck, Lars Michel, Yi Lin, et al.
European Heart Journal. Case Reports|December 13, 2024
Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation: a case reportJulia Vogel, Peter Luedike, Amir Abbas Mahabadi, et al.
Current Heart Failure Reports|February 19, 2025
Prevention of cancer-therapy related cardiac dysfunctionElias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 14, 2026
Gender- and sex-dependent variations in heart failure and cardiomyopathies: a review of the literatureTobias Lerchner, Svenja Roß, Florian Buehning, et al.
International Journal of Molecular Sciences|July 27, 2022
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial InfarctionLars Michel, Sebastian Korste, Armin Spomer, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Heart Failure|April 29, 2020
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity: all you need is a meta-analysis? ReplyLars Michel, Tienush Rassaf, Matthias Totzeck
Herz|June 10, 2020
Oncocardiology: new challenges, new opportunitiesLars Michel, Dirk Schadendorf, Tienush Rassaf
Herz|June 14, 2020
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular systemLars Michel, Matthias Totzeck, Lorenz Lehmann, et al.
Current Heart Failure Reports|April 18, 2024
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac AmyloidosisSimon Wernhart, Lars Michel, Alexander Carpinteiro, et al.
International Journal of Cardiology. Heart & Vasculature|January 30, 2025
The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?Tobias Lerchner, Anke Fender, Dobromir Dobrev, et al.
European Heart Journal|March 8, 2022
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesMatthias Totzeck, Lars Michel, Yi Lin, et al.
European Heart Journal. Case Reports|December 13, 2024
Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation: a case reportJulia Vogel, Peter Luedike, Amir Abbas Mahabadi, et al.
Current Heart Failure Reports|February 19, 2025
Prevention of cancer-therapy related cardiac dysfunctionElias Haj-Yehia, Lars Michel, Raluca I Mincu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 14, 2026
Gender- and sex-dependent variations in heart failure and cardiomyopathies: a review of the literatureTobias Lerchner, Svenja Roß, Florian Buehning, et al.
International Journal of Molecular Sciences|July 27, 2022
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial InfarctionLars Michel, Sebastian Korste, Armin Spomer, et al.
Pageof 7